바로가기
메인메뉴로 바로가기
콘텐츠 바로가기
하단메뉴로 바로가기
패밀리사이트 바로가기



Introduction

HOME > Research > Research institute > Medical Canvergence Research Institute > Introduction

  • Date of Establishment : May 10, 2009
  • Director : Jin-Suck Suh, M.D., Ph.D.
  • Number of Researchers : 12
  • Main Research Areas
    • Development of medical diagnostics based on MBNT technology convergence
      • In vitro diagnostics for personalized cancer therapy
      • In vivo medical imaging devices including one that emits terahertz electromagnetic wave
    • Nano-theragnosis: Development of imaging probes and drug delivery system using nanotechnology for personalized therapy
    • Discovery of original technology for the development of new medicine
    • Regeneration medicine based on stem cells
    • Establishment of a collaboration system for rapid pre-clinical and clinical 144 trial with the Korea Research Institute of Bioscience and Biotechnology (KRIBB)

콘텐츠 처음으로 이동